| Dr Melissa Blackburn, DO | |
|
1200 Old York Rd, Abington, PA 19001-3720 | |
| (215) 481-6784 | |
| (215) 481-4787 |
| Full Name | Dr Melissa Blackburn |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 1200 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164833059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MB10234200 (New Jersey) | Secondary |
| 207V00000X | Obstetrics & Gynecology | OT015786 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Medical Center | Toms river, NJ | Hospital |
| Monmouth Medical Center | Long branch, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Barnabas Health Medical Group Pc | 9537316955 | 558 |
News Archive
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
NewsMed speaks to KNAUER about the company's background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Rex G. Mathew, M.D., F.A.C.E.P., vice president of Emergency Medicine Clinical Operations at Thomas Jefferson University Hospital (TJUH) has been named the Emergency Department Director of the Year by the Emergency Medicine Foundation and Blue Jay Consulting. Dr. Mathew will receive his award at the American College of Emergency Physicians Emergency Department Director's Academy on April 26th.
MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.
› Verified 7 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
NewsMed speaks to KNAUER about the company's background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Rex G. Mathew, M.D., F.A.C.E.P., vice president of Emergency Medicine Clinical Operations at Thomas Jefferson University Hospital (TJUH) has been named the Emergency Department Director of the Year by the Emergency Medicine Foundation and Blue Jay Consulting. Dr. Mathew will receive his award at the American College of Emergency Physicians Emergency Department Director's Academy on April 26th.
MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.
› Verified 7 days ago
| Entity Name | Mpv New Jersey Md Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215391271 PECOS PAC ID: 5991097669 Enrollment ID: O20160718000760 |
News Archive
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
NewsMed speaks to KNAUER about the company's background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Rex G. Mathew, M.D., F.A.C.E.P., vice president of Emergency Medicine Clinical Operations at Thomas Jefferson University Hospital (TJUH) has been named the Emergency Department Director of the Year by the Emergency Medicine Foundation and Blue Jay Consulting. Dr. Mathew will receive his award at the American College of Emergency Physicians Emergency Department Director's Academy on April 26th.
MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Blackburn, DO 312 Professional View Dr, Bldg 300, Freehold, NJ 07728-7904 Ph: (732) 431-1616 | Dr Melissa Blackburn, DO 1200 Old York Rd, Abington, PA 19001-3720 Ph: (215) 481-6784 |
News Archive
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
NewsMed speaks to KNAUER about the company's background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.
Rex G. Mathew, M.D., F.A.C.E.P., vice president of Emergency Medicine Clinical Operations at Thomas Jefferson University Hospital (TJUH) has been named the Emergency Department Director of the Year by the Emergency Medicine Foundation and Blue Jay Consulting. Dr. Mathew will receive his award at the American College of Emergency Physicians Emergency Department Director's Academy on April 26th.
MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.
› Verified 7 days ago
Angela Carracino, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2606 | |
Joel I Polin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1235 Higland Ave, Suite 109, Abington, PA 19001 Phone: 215-572-6222 Fax: 215-481-2048 | |
Jay Scott Schinfeld, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1245 Highland Avenue, Suite 404, Abington, PA 19001 Phone: 215-887-2010 Fax: 215-887-3291 | |
Sarah Gleberman Kirshner, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Bethany Perry, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-6784 Fax: 215-481-3611 | |
Lisa Naujoks, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-6784 | |
Pamela T Carroll, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Department Of Ob/gyn, Abington, PA 19001 Phone: 215-481-6784 |